{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:04:52Z","timestamp":1789923892258,"version":"4.0.1"},"reference-count":38,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2014.0003","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:19:26Z","timestamp":1525252766000},"source":"Crossref","is-referenced-by-count":17,"title":["Breast Cancer in Young Women After Treatment for Hodgkin\u2019s Disease During Childhood or Adolescence"],"prefix":"10.3238","author":[{"given":"G\u00fcnther","family":"Schellong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Riepenhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Ehlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Br\u00e4mswig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"D\u00f6rffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita K.","family":"Schmutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Bick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2014,1,6]]},"reference":[{"key":"10.3238\/arztebl.2014.0003_ref1","doi-asserted-by":"crossref","unstructured":"Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993; 85: 25\u201331.","DOI":"10.1093\/jnci\/85.1.25"},{"key":"10.3238\/arztebl.2014.0003_ref2","doi-asserted-by":"crossref","unstructured":"Bhatia S, Robison LL, Oberlin O, et al.: Breast cancer and other second neoplasms after childhood Hodgkin\u2019s disease. New Engl J Med 1996; 334: 745\u201351","DOI":"10.1056\/NEJM199603213341201"},{"key":"10.3238\/arztebl.2014.0003_ref3","doi-asserted-by":"crossref","unstructured":"Sankila R, Garwicz S, Olsen JH, et al.: Risk of subsequent malignant neoplasms among 1641 Hodgkin\u2019s disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. J Clin Oncol 1996; 14: 1442\u20136.","DOI":"10.1200\/JCO.1996.14.5.1442"},{"key":"10.3238\/arztebl.2014.0003_ref4","doi-asserted-by":"crossref","unstructured":"Bhatia S, Yasni Y, Robison LL, et al.: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin\u2019s disease; Report from the Late Effects Study Group. J Clin Oncol 2003; 21: 4386\u201394.","DOI":"10.1200\/JCO.2003.11.059"},{"key":"10.3238\/arztebl.2014.0003_ref5","doi-asserted-by":"crossref","unstructured":"Travis LB, Hill DA, Dores GM, et al.: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465\u201375.","DOI":"10.1001\/jama.290.4.465"},{"key":"10.3238\/arztebl.2014.0003_ref6","doi-asserted-by":"crossref","unstructured":"Kenney LB, Yasui Y, Inskip PD, et al.: Breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141: 590\u20137.","DOI":"10.7326\/0003-4819-141-8-200410190-00006"},{"key":"10.3238\/arztebl.2014.0003_ref7","doi-asserted-by":"crossref","unstructured":"Basu SK, Schwarz C, Fisher SG, et al.: Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin\u2019s disease. Int J Radiation Oncol Biol Phys 2008; 72: 34\u201340.","DOI":"10.1016\/j.ijrobp.2008.04.068"},{"key":"10.3238\/arztebl.2014.0003_ref8","doi-asserted-by":"crossref","unstructured":"Inskip PD, Robison LL, Stovall M, et al.: Radiation dose and breast cancer risk in the Childhood Cancer Survivor Study. J Clin Oncol 2009; 27: 3901\u20137.","DOI":"10.1200\/JCO.2008.20.7738"},{"key":"10.3238\/arztebl.2014.0003_ref9","doi-asserted-by":"crossref","unstructured":"Alm El-Din MA, Hughes KS, Finkelstein DM, et al.: Breast cancer after treatment of Hodgkin\u2019s lymphoma: Risk factors that really matter. Int J Radiation Oncol Biol Phys 2009; 73: 69\u201374.","DOI":"10.1016\/j.ijrobp.2008.03.066"},{"key":"10.3238\/arztebl.2014.0003_ref10","doi-asserted-by":"crossref","unstructured":"O\u2019Brien MM, Donaldson SS, Balise RR, Whittemore AS, Link MP: Second malignant neoplasms in survivors of pediatric Hodgkin\u2019s lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol 2010; 28: 1232\u20139.","DOI":"10.1200\/JCO.2009.24.8062"},{"key":"10.3238\/arztebl.2014.0003_ref11","doi-asserted-by":"crossref","unstructured":"Moskowitz CS, Chou JF, Wolden SL, et al.: New insights into the risk of breast cancer in childhood cancer survivors treated with chest radiation: A report from the Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study. J Clin Oncol 2012; 30: CRA9513.","DOI":"10.1200\/jco.2012.30.18_suppl.cra9513"},{"key":"10.3238\/arztebl.2014.0003_ref12","doi-asserted-by":"crossref","unstructured":"Swerdlow AJ, Cooke R, Bates A, et al.: Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin\u2019s lymphoma in England and Wales: A national cohort study. J Clin Oncol 2012; 30: 2745\u201352.","DOI":"10.1200\/JCO.2011.38.8835"},{"key":"10.3238\/arztebl.2014.0003_ref13","doi-asserted-by":"crossref","unstructured":"Oeffinger KC, Ford JS, Moskowitz CS, et al.: Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA 2009; 301: 404\u201314.","DOI":"10.1001\/jama.2008.1039"},{"key":"10.3238\/arztebl.2014.0003_ref14","doi-asserted-by":"crossref","unstructured":"Howell SJ, Searle C, Goode V, et al.: The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage. Br J Cancer 2009; 101: 582\u20138.","DOI":"10.1038\/sj.bjc.6605215"},{"key":"10.3238\/arztebl.2014.0003_ref15","doi-asserted-by":"crossref","unstructured":"Terenziani M, Casalini P, Scaperrotta G, et al.: Occurrence of breast cancer after chest wall irradiation for pediatric cancer, as detected by a multimodal screening program. J Radiation Oncol Biol Phys 2013; 85: 35\u20139.","DOI":"10.1016\/j.ijrobp.2012.03.043"},{"key":"10.3238\/arztebl.2014.0003_ref16","doi-asserted-by":"crossref","unstructured":"Colin C, de Vathaire F, No\u00ebl A, et al.: Updated Relevance of Mammographic Screening Modalities in Women Previously Treated with Chest Irradiation for Hodgkin Disease. Radiology 2012; 265: 669\u201376.","DOI":"10.1148\/radiol.12120794"},{"key":"10.3238\/arztebl.2014.0003_ref17","doi-asserted-by":"crossref","unstructured":"Schellong G, Riepenhausen M: Late effects after therapy of Hodgkin\u2019s disease: Update 2003\/04 on overwhelming post \u2013splenectomy infections and secondary malignancies. Klin P\u00e4diatr 2004; 216: 364\u20139.","DOI":"10.1055\/s-2004-832340"},{"key":"10.3238\/arztebl.2014.0003_ref18","doi-asserted-by":"crossref","unstructured":"Bramswig JH, H\u00f6rnig-Franz I, Riepenhausen M, et al.: The challenge of pediatric Hodgkin\u2019s disease: Where is the balance between cure and long-term toxicity? A report of the West German multicenter studies DAL-HD-78, DAL-HD-82 and DAL-HD-85. Leuk Lymphoma 1990; 3: 183\u201393.","DOI":"10.3109\/10428199009050994"},{"key":"10.3238\/arztebl.2014.0003_ref19","doi-asserted-by":"crossref","unstructured":"Schellong G, H\u00f6rnig-Franz I, Rath B, et al.: Reducing radiation dosage to 20\u201330 Gy in combined chemo-\/radiotherapy of Hodgkin\u2019s disease in childhood. A report of the cooperative DAL-HD-87 therapy study. Klin P\u00e4diatr 1994; 206: 253\u201362.","DOI":"10.1055\/s-2008-1046611"},{"key":"10.3238\/arztebl.2014.0003_ref20","doi-asserted-by":"crossref","unstructured":"Schellong G, Potter R, Bramswig JH, et al.: High cure rates and reduced long-term toxicity in pediatric Hodgkin\u2019s disease: The German\u2013Austrian multicenter trial DAL-HD-90. The German\u2013Austrian Pediatric Hodgkin\u2019s Disease Study Group. J Clin Oncol 1999; 17: 3736\u201344.","DOI":"10.1200\/JCO.1999.17.12.3736"},{"key":"10.3238\/arztebl.2014.0003_ref21","doi-asserted-by":"crossref","unstructured":"Bramswig JH, Heimes U, Heiermann E, et al.: The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin\u2019s disease during childhood or adolescence. Cancer 1990; 65: 1298\u2013302.","DOI":"10.1002\/1097-0142(19900315)65:6<1298::AID-CNCR2820650607>3.0.CO;2-W"},{"key":"10.3238\/arztebl.2014.0003_ref22","doi-asserted-by":"crossref","unstructured":"Schellong G, Riepenhausen M, Creutzig U, et al.: Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin\u2019s disease. J Clin Oncol 1997; 15: 2247\u201353.","DOI":"10.1200\/JCO.1997.15.6.2247"},{"key":"10.3238\/arztebl.2014.0003_ref23","doi-asserted-by":"crossref","unstructured":"Schellong G, Riepenhausen M, Bruch C, et al.: Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German\u2013Austrian DAL-HD Studies. Pediatr Blood Cancer 2010; 55: 1145\u201352.","DOI":"10.1002\/pbc.22664"},{"key":"10.3238\/arztebl.2014.0003_ref24","unstructured":"D\u00f6rffel W, Riepenhausen M, Ludwig WD, Schellong G: Langzeitfolgen nach Therapie eines Hodgkin-Lymphoms bei Kindern und Jugendlichen. Journal Onkologie 2010; 09: 449\u201356."},{"key":"10.3238\/arztebl.2014.0003_ref25","doi-asserted-by":"crossref","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u201381.","DOI":"10.1080\/01621459.1958.10501452"},{"key":"10.3238\/arztebl.2014.0003_ref26","doi-asserted-by":"crossref","unstructured":"Gooley TA, Leisenring W, Crowley J, et al.: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695\u2013706.","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O"},{"key":"10.3238\/arztebl.2014.0003_ref27","doi-asserted-by":"crossref","unstructured":"Yasui Y, Liu Y, Neglia JP, et al.: A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol 2003; 158: 1108\u201313.","DOI":"10.1093\/aje\/kwg278"},{"key":"10.3238\/arztebl.2014.0003_ref28","doi-asserted-by":"crossref","unstructured":"Antoniou AC, Cunningham AP, Peto J, et al.: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008, 98: 1457\u201366.","DOI":"10.1038\/sj.bjc.6604305"},{"key":"10.3238\/arztebl.2014.0003_ref29","doi-asserted-by":"crossref","unstructured":"Schmutzler RK, Rhiem K, Breuer P, et al.: Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prev 2006; 15: 483\u20139.","DOI":"10.1097\/01.cej.0000220624.70234.14"},{"key":"10.3238\/arztebl.2014.0003_ref30","doi-asserted-by":"crossref","unstructured":"Meindl A, Ditsch N, Kast K, Rhiem K, Schmutzler RK: Hereditary breast and ovarian cancer\u2014new genes, new treatments, new concepts. Dtsch Arztebl Int 2011; 108(19): 323\u201330.","DOI":"10.3238\/arztebl.2011.0323"},{"key":"10.3238\/arztebl.2014.0003_ref31","unstructured":"Largo RH, Prader A: Pubertal development in Swiss girls. Helv Paediatr Acta 1983; 38: 229\u201343."},{"key":"10.3238\/arztebl.2014.0003_ref32","doi-asserted-by":"crossref","unstructured":"Br\u00e4mswig JH, D\u00fcbbers A: Disorders of pubertal development. Dtsch Arztebl Int 2009; 106(17): 295\u2013304.","DOI":"10.3238\/arztebl.2009.0295"},{"key":"10.3238\/arztebl.2014.0003_ref33","unstructured":"Demoor-Goldschmidt C, Supiot S, Mah\u00e9 MA: Breast cancer after radiotherapy: risk factors and suggestion for breast delineation as an organ at risk in the prepuberal girl. Cancer Radiother 2012; 16: 140\u201351."},{"key":"10.3238\/arztebl.2014.0003_ref34","doi-asserted-by":"crossref","unstructured":"Henderson TO, Amsterdam A, Bhatia S, et al.: Systematic Review: Surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 2010; 152: 444\u201355.","DOI":"10.7326\/0003-4819-152-7-201004060-00009"},{"key":"10.3238\/arztebl.2014.0003_ref35","doi-asserted-by":"crossref","unstructured":"van Leeuwen FE, Klokman WJ, Stovall M, et al.: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease. J Natl Cancer Inst 2003; 95: 971\u201380.","DOI":"10.1093\/jnci\/95.13.971"},{"key":"10.3238\/arztebl.2014.0003_ref36","doi-asserted-by":"crossref","unstructured":"R\u00f6ssig C, J\u00fcrgens H, Schrappe M, et al.: Effective Childhood Cancer Treatment: The Impact of Large Scale Clinical Trials in Germany and Austria. Pediatr Blood Cancer 2013; 60: 1574\u201381.","DOI":"10.1002\/pbc.24598"},{"key":"10.3238\/arztebl.2014.0003_ref37","doi-asserted-by":"crossref","unstructured":"D\u00f6rffel W, R\u00fchl U, L\u00fcders H, et al.: Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: Final results of the multinational trial GPOH-HD95. J Clin Oncol 2013; 31: 1562\u20138.","DOI":"10.1200\/JCO.2012.45.3266"},{"key":"10.3238\/arztebl.2014.0003_ref38","doi-asserted-by":"crossref","unstructured":"Mauz-K\u00f6rholz C, Hasenclever D, D\u00f6rffel W, et al.: Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric hodgkin\u2019s lymphoma: The GPOH-HD-2002 Study. J Clin Oncol 2010; 28: 3680\u20136.","DOI":"10.1200\/JCO.2009.26.9381"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:07:54Z","timestamp":1638796074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,6]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2014.0003","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,6]]}}}